The ShcA SH2 domain engages a 14-3-3/PI3′K signaling complex and promotes breast cancer cell survival
Authors:
- J Ursini-SiegelJUJ Ursini-Siegel
- W R HardyWHW R Hardy
- Y ZhengYZY Zheng
- C LingCLC Ling
- D ZuoDZD Zuo
- C ZhangCZC Zhang
- L PodmoreLPL Podmore
- T PawsonTPT Pawson
- W J MullerWMW J Muller
- 30 January 2012
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 31 (48) , 5038-5044
Abstract
The ShcA adapter protein transmits activating signals downstream of receptor and cytoplasmic tyrosine kinases through the establishment of phosphotyrosine-dependent complexes. In this regard, ShcA possesses both a phosphotyrosine-binding domain (PTB) and Src homology 2 domain (SH2), which bind phosphotyrosine residues in a sequence-specific manner. Although the majority of receptor tyrosine kinases expressed in breast cancer cells bind the PTB domain, very little is known regarding the biological importance of SH2-driven ShcA signaling during mammary tumorigenesis. To address this, we employed transgenic mice expressing a mutant ShcA allele harboring a non-functional SH2 domain (ShcR397K) under the transcriptional control of the endogenous ShcA promoter. Using transplantation approaches, we demonstrate that SH2-dependent ShcA signaling within the mammary epithelial compartment is essential for breast tumor outgrowth, survival and the development of lung metastases. We further show that the ShcA SH2 domain activates the AKT pathway, potentially through a novel SH2-mediated complex between ShcA, 14-3-3ζ and the p85 regulatory subunit of phosphatidylinositol 3 (PI3') kinase. This study is the first to demonstrate that the SH2 domain of ShcA is critical for tumor survival during mammary tumorigenesis.Keywords
This publication has 43 references indexed in Scilit:
- Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunitOncogene, 2011
- A novel role for 14–3–3σ in regulating epithelial cell polarityGenes & Development, 2010
- 14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal TransitionCancer Cell, 2009
- 14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell SurvivalJournal of Biological Chemistry, 2009
- 14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell SurvivalCancer Research, 2009
- The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer developmentTrends in Cell Biology, 2009
- A Novel Binding Factor of 14-3-3β Functions as a Transcriptional Repressor and Promotes Anchorage-independent Growth, Tumorigenicity, and MetastasisJournal of Biological Chemistry, 2008
- ShcA signalling is essential for tumour progression in mouse models of human breast cancerThe EMBO Journal, 2008
- Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor DevelopmentMolecular and Cellular Biology, 2007
- Combinatorial ShcA Docking Interactions Support Diversity in Tissue MorphogenesisScience, 2007